 SAN DIEGO, CA ACCESSWIRE January 5, 2022 Dermata Therapeutics, Inc. NASDAQ:DRMA Dermata or the Company, a clinical-stage biotechnology company focusing on the treatment of medical and aesthetic skin conditions, today announced that Gerry Proehl, Dermatas Chairman of the Board, President, and Chief Executive Officer, will present a company overview at the H.C. Wainwright BioConnect Virtual Conference being held January 10-13, 2022. 